Baljiwan Medicines Private Limited, a active private limited company, was established on 14 September 1989 in Uttar Pradesh, Uttar Pradesh, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24231UP1989PTC011170. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.30 M.
It upholds a compliant status. Employing 22 professional, Its leadership includes Saurabh Agarwal (Director), Richa Agrawal (Director). Past directors included Jyoti Swaroop Agarwal, Shanti Swaroop Agrawal, Vinayaka Agrawal. It holds ₹1.23 Cr open charges and ₹5.25 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 5Th K.M Delhi Road Nearsarsauli Aligarh, Uttar Pradesh, Uttar Pradesh.
U24231UP1989PTC011170
011170
14 September 1989
₹2.50 M
₹1.30 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Baljiwan Medicines Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saurabh Agarwal | Director | 20 Apr 2015 | Current |
| Richa Agrawal | Director | 20 Apr 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 08 May 2016 | Past |
| Pramod Abcsdd | Director | 12 Feb 2010 | Past |
| Pramod Abcsdd | Director | 07 Nov 2015 | Past |
| Pramod Abcsdd | Director | 07 Nov 2015 | Past |
| Pramod Abcsdd | Director | 08 Nov 2023 | Past |
| Pramod Abcsdd | Director | 07 Nov 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Baljiwan Medicines Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 25.97% increase. The company also saw a slight improvement in profitability, with a 5.15% increase in profit. The company's net worth moved up by a moderate rise of 4.89%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Baljiwan Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,250,000.00
₹5,250,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jun 2022 | Canara Bank | ₹1.00 M | Open |
| 21 Aug 2017 | Canara Bank | ₹1.00 Cr | Open |
| 21 Aug 2017 | Canara Bank | ₹1.25 M | Open |
| 15 Apr 2020 | Canara Bank | ₹3.50 M | Satisfied |
| 31 Mar 2018 | Canara Bank | ₹1.75 M | Satisfied |
Explore comprehensive loan charge details -
Baljiwan Medicines has a workforce of 22 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Baljiwan Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baljiwan Medicines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Baljiwan Medicines Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Baljiwan Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
The activity A charge registered on 31 Mar 2018 via Charge ID 100176408 with Canara Bank was fully satisfied on 26 Oct 2023. was completed.
The activity A charge registered on 15 Apr 2020 via Charge ID 100341096 with Canara Bank was fully satisfied on 10 Aug 2023. was completed.
Progress on A charge with Canara Bank amounted to Rs. 1.00 M with Charge ID 100583720 was registered on 10 Jun 2022. was documented.
The activity A charge with Canara Bank amounted to Rs. 3.50 M with Charge ID 100341096 was registered on 15 Apr 2020. was completed.
The CIN of Baljiwan Medicines Private Limited is U24231UP1989PTC011170.
Baljiwan Medicines Private Limited is headquartered at 5Th K.M Delhi Road Nearsarsauli Aligarh, Uttar Pradesh, Uttar Pradesh.
Baljiwan Medicines Private Limited was incorporated on 14 September 1989.
The current directors of Baljiwan Medicines Private Limited are
The primary industry of Baljiwan Medicines Private Limited is Manufacturing.
Baljiwan Medicines Private Limited is unlisted.
The authorized capital of Baljiwan Medicines Private Limited is ₹2.50 M, and the paid-up capital is ₹1.30 M.
The compliance status of Baljiwan Medicines Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX